about
New approaches for the treatment of diabetic macular oedema: recommendations by an expert panelThe current role of thiazolidinediones in diabetes management.Intravitreal bevacizumab alone versus combined with macular photocoagulation in diabetic macular edemaLaser treatment of diabetic macular edema.Algorithm for the Measure of Vitreous Hyperreflective Foci in Optical Coherence Tomographic Scans of Patients With Diabetic Macular Edema.Assessment of the Heidelberg Retina Tomograph in the detection of sight-threatening diabetic maculopathy.Improvement of macular function by membrane differential filtration in diabetic retinopathy.Correlation of a scanning laser derived oedema index and visual function following grid laser treatment for diabetic macular oedema.A severity scale for diabetic macular edema developed from ETDRS data.Scanning laser tomography Z profile signal width as an objective index of macular retinal thickening.Conditioned medium from mixed retinal pigmented epithelium and Müller cell cultures reduces in vitro permeability of retinal vascular endothelial cellsTreatments for choroidal and retinal neovascularization: a focus on oligonucleotide therapy and delivery for the regulation of gene function.The effect of posterior subtenon methylprednisolone acetate in the refractory diabetic macular edema: a prospective nonrandomized interventional case series.Emerging pharmacotherapies for diabetic macular edema.Diabetic retinopathy: an updateIntravitreal bevacizumab for treatment of diabetic macular edemaRole of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy.Pharmacologic therapies for diabetic retinopathy and diabetic macular edemaExploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation.Infliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double-blind, placebo-controlled, crossover, 32-week study.The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial DysfunctionIntravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture.Effect of adding oral calcium dobesilate to laser photocoagulation on the macular thickness in patients with diabetic macular edema: a randomized clinical trialRanibizumab: in diabetic macular oedema.Characterization of a mouse model of hyperglycemia and retinal neovascularizationIntravitreal versus subtenon triamcinolone acetonide injection for diabetic macular edema: a systematic review and meta-analysis.Review of therapeutic advances in diabetic retinopathy.Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema.Intravitreal injection of Bevacizumab in diabetic macular edemaPreventing microvascular diabetic complications in children and adolescents: looking beyond glycaemic control.Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant.The Chemokine Platelet Factor-4 Variant (PF-4var)/CXCL4L1 Inhibits Diabetes-Induced Blood-Retinal Barrier BreakdownThe correlation between retinal sensitivity assessed by microperimetry and contrast sensitivity in diabetic macular oedema.Imbalance of the nerve growth factor and its precursor as a potential biomarker for diabetic retinopathy.Quantitative assessment of macular thickness in normal subjects and patients with diabetic retinopathy by scanning retinal thickness analyser.Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factors.A novel intravitreal fluocinolone acetonide implant (Iluvien(®)) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case seriesEfficacy and safety of different doses of a slow-release corticosteroid implant for macular edema: meta-analysis of randomized controlled trialsTreatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapy.
P2860
Q26853239-A189DD87-A39D-437E-A218-37161EF2BBB9Q30250347-B854C0C2-B45E-4042-AD8E-1F0B2C5551AAQ30473844-C65CB06E-8499-4300-9452-69EC214A89F5Q30661390-4975DACD-CEFD-4758-92AA-020BA82275B5Q30698571-86E460F1-E963-46CF-B920-F51CDF0C260FQ30752953-93AC592A-CF3C-49EF-A3BD-86C2D272D194Q30987529-1B186F94-7762-492D-B638-D21B1D65C7C9Q31135425-EB068DB2-51B6-4368-93A5-54AE2F980052Q31158479-D048A98A-B89E-4C28-BB36-D2B0A14EB05AQ32061918-CCF2D65F-3F77-4E49-B677-D665EE3EBF9DQ33203899-314731B0-86E1-42B5-AC88-0E6ECC6C9083Q33211168-0BCD235A-7E50-4E57-9655-A108D104AFE5Q33238893-C9A77240-2BAB-459D-B6FB-EC84FC52DD01Q33304852-EF7126A2-98C8-4D7F-959B-DA2FF57B166DQ33328784-0382C8E2-43E2-403F-AA0F-82C106191F7FQ33425236-1989D79C-3EB2-4FF5-B094-E300873FFF53Q33431322-1CE765B6-9EBD-4C2D-A8C9-C2FA78CDE553Q33492340-8694F7F8-2064-42B1-BDB0-97A1385ABFCBQ33518322-D2CA50FE-9B15-4C30-8169-FEFC1D177FB8Q33562586-2BC5A5EA-193C-4D04-BF08-1DF42C2100B4Q33653112-F3EC0D90-36C8-4D46-81B6-8C53B3494B70Q33839167-5277923E-7D12-462B-893C-F7793241A269Q33902419-739FAEA1-FFE0-4DEE-B540-C27C6782FE20Q34063874-E4EB76A1-D099-43A3-AD02-CFCBC968D499Q34166795-1810B790-A4DF-4F93-885C-CE4C514673F5Q34254645-78E8145E-BEF6-4202-BA85-2ECC0B608802Q34336983-17D287E4-C223-4B2F-AEC4-E64CFBF4D3BEQ34475449-065B9A95-CBDA-40CE-9E30-988434C8E644Q34758061-05461AD2-2C1B-4EDE-BCCC-4C89608D1711Q35061041-14996A3C-2E79-48C9-8B5A-8A18B951698EQ35095210-C23CAFC6-1AC3-4B82-BF99-DC15B80DD1D4Q35128723-10BE8F4F-858B-40B3-AF36-FE361F6A51F9Q35195333-7ECB4AA3-0232-4481-8203-5E2E29F5B109Q35201651-ECC86B7D-E0FF-450A-98B5-FC8C1BCC8B2FQ35234189-3300D3AF-E414-418E-AC70-D7BE1E151F60Q35307389-BEC69E28-75ED-4312-8110-399C0C627B33Q35315717-F55664B3-4A1B-4384-A0F6-4D2ABCA77CA3Q35592903-D2040030-F635-42AE-A562-9E3CAD569565Q35594036-AB8136C3-152E-49C5-9393-146B50759EADQ35870506-0AAE5179-C032-4BB6-8AE8-3B2B174375FF
P2860
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Macular edema. A complication of diabetic retinopathy.
@ast
Macular edema. A complication of diabetic retinopathy.
@en
type
label
Macular edema. A complication of diabetic retinopathy.
@ast
Macular edema. A complication of diabetic retinopathy.
@en
prefLabel
Macular edema. A complication of diabetic retinopathy.
@ast
Macular edema. A complication of diabetic retinopathy.
@en
P1476
Macular edema. A complication of diabetic retinopathy.
@en
P2093
P304
P356
10.1016/0039-6257(84)90227-3
P478
P577
1984-05-01T00:00:00Z